Acadia Healthcare (ACHC) Scheduled to Post Quarterly Earnings on Wednesday

Acadia Healthcare (NASDAQ:ACHC) will issue its quarterly earnings data after the market closes on Wednesday, July 31st. Analysts expect the company to announce earnings of $0.88 per share for the quarter. Individual that are interested in registering for the company’s earnings conference call can do so using this link.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings results on Thursday, May 2nd. The company reported $0.84 earnings per share for the quarter, topping the consensus estimate of $0.80 by $0.04. Acadia Healthcare had a positive return on equity of 11.49% and a negative net margin of 0.38%. The company had revenue of $768.10 million for the quarter, compared to the consensus estimate of $779.20 million. During the same quarter in the prior year, the business earned $0.75 EPS. Acadia Healthcare’s revenue was up 9.1% on a year-over-year basis. On average, analysts expect Acadia Healthcare to post $4 EPS for the current fiscal year and $4 EPS for the next fiscal year.

Acadia Healthcare Trading Down 1.6 %

Shares of NASDAQ ACHC opened at $65.53 on Tuesday. The stock’s 50-day moving average is $66.85 and its two-hundred day moving average is $74.05. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.27 and a current ratio of 1.27. Acadia Healthcare has a 1-year low of $62.04 and a 1-year high of $87.77.

Analyst Ratings Changes

A number of research firms have recently commented on ACHC. TD Cowen dropped their price objective on Acadia Healthcare from $101.00 to $91.00 and set a “buy” rating on the stock in a report on Friday, May 17th. Deutsche Bank Aktiengesellschaft upgraded Acadia Healthcare from a “sell” rating to a “hold” rating and set a $70.00 price objective on the stock in a report on Thursday, April 25th. Royal Bank of Canada reissued an “outperform” rating and issued a $94.00 target price on shares of Acadia Healthcare in a research report on Wednesday, May 22nd. StockNews.com cut Acadia Healthcare from a “hold” rating to a “sell” rating in a research report on Tuesday, May 21st. Finally, Barclays decreased their target price on Acadia Healthcare from $91.00 to $89.00 and set an “overweight” rating for the company in a research report on Wednesday, May 15th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $87.56.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.